SEO URLwww.firestrike.ai/deals/modella-ai-astrazeneca-acquisition-2026

acquisitionAnnounced · Jan 13, 2026Artificial Intelligence in Life SciencesSource · CredibleArticle · Factual

Modella AI · AstraZeneca

AstraZeneca acquires Modella AI

David Najork · Founding Software Engineer

Announced Jan 13, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

—

Target

Modella AI

Acquirer

AstraZeneca

Full Acquisition

Status

Completed

AstraZeneca agreed to acquire Modella AI. Reported deal value: Undisclosed. Status: Completed. Sector: Artificial Intelligence in Life Sciences. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.

The acquisition follows a multi-year agreement with AstraZeneca announced in July 2025 and will integrate Modella AI generative and agentic AI platform into AstraZeneca oncology research and development organization, supporting efforts to accelerate clinical development, enhance biomarker discovery, and enable the next wave of data- driven decision-making across the pipeline

Deal timeline

Announced

Jan 13, 2026 · 01net.it

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Artificial Intelligence in Life Sciences. Figures and status may change as sources update.

Sources: 01net.it · Primary article · FireStrike proprietary index